Literature DB >> 16876085

Radical treatment of axillary osmidrosis by subdermal excision of apocrine glands: a prospective study in 31 cases.

J G Qian1, X J Wang.   

Abstract

Axillary osmidrosis is a troublesome and distressing problem. Medical treatment is only temporally effective. From March 2003 to November 2004, 36 patients with axillary osmidrosis (nine cases combined with axillary hyperhidrosis) have been treated by excision of the subcutaneous glands via a small transverse incision, of which 31 cases could be followed up for a minimum of 3 months (average 7.3 months). In terms of malodour elimination, 30 cases had good results, one had fair result, and none had a poor result. All patients reported significant reducing of sweating, especially those with hyperhidrosis. Postoperative complications were minor, including small haematoma (one axillae), small seroma (two axillae), and superficial epidermal necrosis (21 axillae) which were all spontaneously healed within a week. Twenty-nine (93.5%) patients were very satisfied with the procedure and two (6.5%) patients satisfied, with none regretful. The operation has the advantage of a high success rate in radical elimination of the malodour with minor complications.

Entities:  

Mesh:

Year:  2006        PMID: 16876085     DOI: 10.1016/j.bjps.2005.10.012

Source DB:  PubMed          Journal:  J Plast Reconstr Aesthet Surg        ISSN: 1748-6815            Impact factor:   2.740


  2 in total

1.  A Prospective, Long-Term Follow-Up Study of 1,444 nm Nd:YAG Laser: A New Modality for Treating Axillary Bromhidrosis.

Authors:  Sung Kyu Jung; Hee Won Jang; Hee Joo Kim; Sang Geun Lee; Kyung Goo Lee; Sun Yae Kim; Sang Min Yi; Jae Hwan Kim; Il-Hwan Kim
Journal:  Ann Dermatol       Date:  2014-04-30       Impact factor: 1.444

Review 2.  Surgical treatment of axillary hyperhidrosis by suction-curettage of sweat glands.

Authors:  Rebeca Maffra de Rezende; Flávio Barbosa Luz
Journal:  An Bras Dermatol       Date:  2014 Nov-Dec       Impact factor: 1.896

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.